Inpharma Weekly

, Volume 1489, Issue 1, pp 19–19 | Cite as

Losartan, not spironolactone, reduces LVM and sympathetic activity

Clinical study
  • 4 Downloads

Keywords

Hypertension Obesity Losartan Randomise Study Obese Subject 

Copyright information

© Adis International Ltd 2005

Personalised recommendations